Nautilus Biotechnology, Inc. · NASDAQ:NAUT
Sujal Patel reported a 16.30% stake in Nautilus Biotechnology, Inc. (Schedule 13D/A)
Event Mar 2, 2026 · Filed Mar 4, 2026
Sujal Patel reported a 16.30% stake in Nautilus Biotechnology, Inc., 21,249,965 shares, with active intent on Mar 2, 2026. Filed Mar 4, 2026 (Schedule 13D/A).
- Stake
- 16.30%
- Shares
- 21,249,965
- Intent
- Active
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sujal Patel | 16.30% | 21,249,965 |
Source
Related
- Nautilus Biotechnology, Inc.
- Sujal Patel
- Nautilus Biotechnology, Inc. shareholders
- Schedule 13D/A · Sujal Patel · Mar 5, 2025
- Schedule 13D/A · Andreessen Marc L · Sep 11, 2026
- Schedule 13D/A · Andreessen Marc L · Aug 28, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13D/A · Andreessen Marc L · Jun 30, 2026
- Form 4 · AH Bio Fund II, L.P. · Jun 4, 2026